Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 1, 2009, Pages 174-178

  Setkowicz, Malgorzata ^a   Mastalerz, Lucyna ^a   Podolec Rubis, Magdalena ^a   Sanak, Marek ^a   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

aspirin sensitivity; aspirin induced urticaria; eicosanoids; leukotriene E4; prostaglandin D2; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ICOSANOID; LEUKOTRIENE E4; PLACEBO; PROSTAGLANDIN D2;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HUMAN; ICOSANOID METABOLISM; IDIOPATHIC DISEASE; IMMUNE RESPONSE; MALE; METABOLITE; PRIORITY JOURNAL; URINARY EXCRETION; URTICARIA;

ADULT; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DINOPROST; DRUG ERUPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED; URTICARIA;

EID: 58149133927     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.09.005     Document Type: Article

References (23)

1. Kaplan A.P. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 346 (2002) 175-179
2. Kaplan A.P. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 114 (2004) 465-474
3. Grattan C.E., and Humphreys F. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 157 (2007) 1116-1123
4. Greaves M.W., and Tan K.T. Chronic urticaria: recent advances. Clin Rev Allergy Immunol 33 (2007) 134-143
5. Zuberbier T., Bindslev-Jensen C., Canonica W., Grattan C.E., Greaves M.W., Henz B.M., et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 61 (2006) 321-331
6. Stevenson D.D., Simon R.A., and Zuraw B.L. Sensitivity to aspirin and nonsteroidal antiinfalmmatory drugs. Middelton's allergy, principles and practice. 6th ed. (2003), Mosby, Inc, St Louis 1695-1710
7. Grzelewska-Rzymowska I., Rozniecki J., and Szmidt M. Aspirin desensitization in patients with aspirin-induced urticaria and angioedema. Allergol Immunopathol 16 (1988) 305-308
8. Zembowicz A., Mastalerz L., Setkowicz M., Radziszewski W., and Szczeklik A. Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria. J Cutan Pathol 31 (2004) 323-329
9. Mastalerz L., Setkowicz M., Sanak M., and Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 113 (2004) 771-775
10. Zembowicz A., Mastalerz L., Setkowicz M., Radziszewski W., and Szczeklik A. Safety of cyclooxygenase II inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to non-steroidal anti-inflammatory drugs. Arch Dermatol 139 (2003) 1577-1582
11. Ye Y.M., Kim J.E., Kim S.H., Suh C.H., Nam D.H., and Park H.S. Clinical characteristics of chronic urticaria with aspirin sensitivity. Korean J Asthma Allergy Clin Immunol 25 (2005) 194-199
12. Sanchez-Borges M., Capriles-Hulett A., and Caballero-Fonseca F. How safe are COX-2 inhibitors in NSAIDs-sensitive subjects with cutaneous reactions?. ACI Int 15 (2003) 110-113
13. Asero R. Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. Clin Exp Dermatol 32 (2007) 661-663
14. Mastalerz L., Setkowicz M., Sanak M., Rybarczyk H., and Szczeklik A. Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant. Br J Dermatol 154 (2006) 256-260
15. *0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin Exp Allergy 35 (2005) 339-344
16. Nizankowska-Mogilnicka E., Bochenek G., Mastalerz L., Swierczyńska M., Picado C., Scadding G., et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62 (2007) 1111-1118
17. Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., and Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328 (1993) 1599-1604
18. Fiebiger E., Maurer D., Holub H., Reininger B., Hartmann G., Woisetschläger M., et al. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?. J Clin Invest 96 (1995) 2606-2612
19. Asero R., Tedeschi A., and Lorini M. Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann Allergy Asthma Immunol 88 (2002) 468-472
20. Szczeklik A., Nizankowska E., Serafin A., Dyczek A., Duplaga M., and Musial J. Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med 152 (1995) 1753-1756
21. Mastalerz L., Sanak M., Gawlewicz-Mroczka A., Gielicz A., Cmiel A., and Szczeklik A. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax 63 (2008) 27-34
22. Bochenek G., Nizankowska E., Gielicz A., Swierczyńska M., and Szczeklik A. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 59 (2004) 459-464
23. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., and Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346 (2002) 1699-1705